Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Sell
19,416
-35,278
-65% -$1.58M 0.03% 140
2026
Q1
$2.64M Buy
54,694
+6,977
+15% +$325K 0.09% 94
2025
Q4
$2.31M Buy
47,717
+573
+1% +$28.4K 0.09% 99
2025
Q3
$2.23M Buy
47,144
+2,109
+5% +$102K 0.09% 102
2025
Q2
$2.18M Buy
45,035
+1,838
+4% +$93.9K 0.1% 101
2025
Q1
$2.4M Buy
43,197
+1,360
+3% +$73.6K 0.12% 88
2024
Q4
$2.02M Buy
41,837
+457
+1% +$23.2K 0.1% 96
2024
Q3
$2.38M Buy
41,380
+2,823
+7% +$152K 0.12% 89
2024
Q2
$1.87M Buy
+38,557
New +$1.86M 0.1% 90

Other funds holding SNY

Aviso Financial's SNY Position: Q2 2026 in Review

Aviso Financial reduced its Sanofi (SNY) stake by 65% in Q2 2026, selling an estimated $1.58M and leaving 19,416 shares worth $828K. The position accounts for 0.03% of the portfolio, ranked #140.

Aviso Financial first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.64M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Aviso Financial held 19,416 shares of Sanofi worth $828K as of Q2 2026.
  • Aviso Financial sold 35,278 Sanofi shares in Q2 2026, an estimated $1.58M.
  • Sanofi made up 0.03% of Aviso Financial's portfolio in Q2 2026, its #140 holding.
  • Aviso Financial first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
  • Aviso Financial's Sanofi position peaked at $2.64M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.